 |
DNA-lipid complex (DMRIE/DOPE)/plasmid vector (VCL-1102, Vical) expressing human interleukin-2 |
|---|---|
| Trade Name | Leuvectin |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-28 00:00:00 |
| Sponsor | Vical Incorporated;9373 Towne Center Dr., Suite 100;San Diego, California, 92121 |
